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Acute injuries of heart, liver, and kid-
ney, which present clinically as diverse
syndromes, share numerous patho-
physiological mechanisms. Survival of
dedifferentiated parenchymal cells
and/or widespread proliferation is
often spoken of as a potential mechan-
ism of repair for acute injuries.
Recently, two types of responses after
acute organ failure have appeared to
be shared in the liver, heart, and kid-
ney: (i) surviving differentiated par-
enchymal cells undergo cell
hypertrophy via polyploidization; and
(ii) a population of progenitors, mostly
identified as resident, more immature
diploid parenchymal cells, self-renew
and differentiate to replace lost cells.
In order to guarantee uninterrupted
life-saving functional performance after
acute failure, essential organs such as
the heart, liver, and kidney avoid wide-
spread proliferation that would be lar-
gely counterproductive because it
implies a transient loss of the specia-
lized cellular functions. Therefore,
these organs require polyploidization
in order to sustain organ function.
In the liver, polyploidization after acute
failure is the predominant but not the
only response. Indeed, the increase in
hepatocyte ploidy precedes the prolif-
eration of diploid hepatocyte progeni-
tors. Polyploidization of hepatocytes
drives functional recovery, increasing
the metabolic function in output,
whereas, hepatocyte progenitor prolif-
eration drives the restoration of liver
mass by generating new hepatocytes.
In the heart, it is still debated whether
newly generated cardiomyocytes ori-
ginate from pre-existing cardiomyo-
cytes that retain their proliferative
capacity throughout adulthood or from
a population of cardiomyocyteIn acute organ failure, rapid compensation of function loss assures survival.
Dedifferentiation and/or proliferation of surviving parenchymal cells could
imply a transient (and potentially fatal) impairment of residual functional per-
formance. However, evolution has selected two flexible life-saving mecha-
nisms acting synergistically on organ function recovery. Sustaining residual
performance is possible when the remnant differentiated parenchymal cells
avoid cell division, but increase function by undergoing hypertrophy via endor-
eplication, leading to polyploid cells. In addition, tissue progenitors, represent-
ing a subset of less-differentiated and/or self-renewing parenchymal cells
completing cytokinesis, proliferate and differentiate to regenerate lost paren-
chymal cells. Here, we review the evolving evidence on polyploidization and
progenitor-driven regeneration in acute liver, heart, and kidney failure with
evolutionary advantages and trade-offs in organ repair.
How to Survive Acute Organ Failure?
Acute injury-related organ failure is a global healthcare challenge with a high risk of mortality,
even in settings of intensive care and availability of artificial organ replacements [1–3]. In those
surviving an episode of acute organ failure (see Glossary), the related tissue remodeling often
results in subsequent chronic organ disease, significantly affecting long-term morbidity, mor-
tality, and healthcare costs (see Clinician’s Corner) [1–3]. A better understanding of the cellular
and molecular mechanisms responsible for acute organ failure may help to limit its devastating
short- as well as long-term consequences in the future.
Evolution has provided a series of compensatory mechanisms to minimize the risk of fatal acute
organ failure due to infections, poisoning, or hypovolemia, which include immunoregulatory
signaling pathways limiting overshooting inflammation, antioxidant signaling pathways reduc-
ing cell stress, and neurohumoral responses maintaining blood pressure and organ perfusion,
respectively [4]. Moreover, injured tissues must also recover lost functional performance by
compensating for parenchymal cell loss. For example, injury-related necrosis of cardiomyo-
cytes, hepatocytes, and tubular epithelial cells directly cause acute cardiac, hepatic, or renal
failure, respectively (see Clinician’s Corner) [1–3]. How do these organs sustain residual
function during acute failure and which mechanisms promote the recovery of lost function
at the cellular level?
In this review, we discuss the pathophysiology of acute organ failure focusing on tissue regenera-
tion via cell proliferation and cell polyploidization via endoreplication as the main mechanisms
to restore tissue integrity and to rapidly recover organ function [5–8]. We will limit our discussion to
heart, liver, and kidney injury, which present themselves clinically as diverse syndromes, although
theysharenumerouspathophysiologicalmechanisms(seeClinician’sCorner),andforwhichdataonTrends in Molecular Medicine, Month Year, Vol. xx, No. yy https://doi.org/10.1016/j.molmed.2019.02.006 1
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progenitors. Cardiomyocyte progeni-
tors can proliferate following injury
but this ability declines with aging in
the mammalian heart. In the mamma-
lian neonate the heart exhibits a high
regenerative capacity due to the pre-
sence of diploid cardiomyocyte pro-
genitors. In the mammalian adult
heart, the regenerative capacity is
almost lost and an increase of poly-
ploidy results in scars in the long run.
In the kidney, polyploidization in
response to injury, was known solely
in podocytes. However, recent find-
ings have demonstrated that injured
tubules respond to acute tubular
necrosis through two main mechan-
isms: (i) endoreplication-mediated
hypertrophy of remnant tubular epithe-
lial cells, aiming to sustain renal func-
tion despite significant epithelial cell
necrosis; and (ii) survival and prolifera-
tion of tubular progenitors, aiming to
replace tubular cell loss. Since poly-
ploid cells mostly maintain a single
nucleus, their identification has
become feasible thanks to an
advanced technology of cell cycle
phase live imaging combined with
DNA quantitation.
Benefits of polyploidization and prolif-
eration associate with distinct trade-
offs, including fibrosis, senescence,
and cancer. Evolution has favored
the coexistence of both mechanisms
in the same organs, ensuring a correct
self-balance of these responses.
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@Twitter: @PRomagnaniboth regeneration and polyploidization have recently become available. We envision that a better
understanding of the functional contribution of polyploidization and regeneration could help to refine
potential targets for therapeutic interventions that aim at improving the short- and long-term
outcomes of acute organ failure.
Parenchymal Cell Loss Induces Two Types of Responses in Surviving Cells
Heart, liver, and kidney require repair strategies that guarantee uninterrupted life-saving
functional performance such as blood circulation and metabolic homeostasis. The life-saving
functions of these organs rely on highly differentiated parenchymal cells that usually no longer
divide, or, if they do, may succumb to mitotic catastrophe [9,10]. It is interesting to note that
surviving parenchymal cell dedifferentiation and/or widespread proliferation were often
spoken of as potential repair mechanisms for acute injury [11–15].
However, widespread parenchymal cell dedifferentiation and/or proliferation would be largely
counterproductive in acute organ failure because they imply a transient loss of specialized
cellular functions. If the remnant parenchymal cells that sustain minimal residual function of an
organ such as the heart, liver, or kidney were to undergo widespread mitosis, this would
further reduce functional performance, which might become critical and, in the worst case, lead
to death [16–18]. Indeed, cytoskeleton structure [16,17] and cell polarity [18] can be reiteratively
lost during mitosis and cytokinesis, correlating with transient adhesion disengagement and
dramatic deformation of organism morphology [18]. However, evolution has selected alterna-
tive solutions and minimized the mitotic ability of differentiated parenchymal cells [19,20]. In
recent years, evolving evidence has revealed that two main response programs sustain residual
functional performance and enforce recovery upon acute organ injury.
Local Progenitor Cells Regenerate Lost Parenchymal Cells by Proliferation and
Differentiation
Progenitors are a small subset of parenchymal cells that reside inside adult organs in a more
immature structural and functional differentiation state, and hence, do not contribute to organ
function, and maintain the capacity to quickly undergo mitosis and to self-renew by asymmetric
division (Figure 1) [6,21–24]. In adult liver, heart, and kidney such progenitors have been
identified as resident diploid parenchymal cells with the capacity to self-renew and differentiate
in order to replace lost cells (Figure 1) [5,7,8]. Progenitor cells start to contribute to organ
function only once mitosis and the differentiation process have been completed.
Polyploidization and Hypertrophy of Remnant Parenchymal Cells Recover Lost Organ
Function
Surviving differentiated parenchymal cells, facing increasing functional demands during organ
failure, cannot go through celldivision and instead increase their functional capacity by undergoing
hypertrophy via polyploidization while maintaining functional performance (Figure 1) [5,7,8,25].
Polyploidization is a consequence of the alternative cell cycle; a process known as endoreplication
that can generate either mononucleated polyploid cells via the endocycle [26] or mono/multinu-
cleated polyploid cells via endomitosis (Figure 1) [27]. Polyploid cells also occur in the absence of
injury, at least in the liver and heart [21,28]. Therefore, there is a normal or healthy degree of
polyploidy in the tissues, and the capacity for additional polyploidization provides unique oppor-
tunities in response to injury [21,28]. Indeed, polyploidization allows an increase in the gene copy
number in response to a need to quickly support an increased functional request for a higher
metabolic output while persistently maintaining differentiated and specialized cell functions [25].
Strikingly, there is a proportional tissue injury response-ploidy that increases with cell number loss,
suggesting that cells respond to injury, and according to its severity, by restoring the genomic2 Trends in Molecular Medicine, Month Year, Vol. xx, No. yy
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Glossary
Acute organ failure: acute loss of
organ function to such a degree that
physiological homeostasis cannot be
maintained.
Acute organ injury: acute harm to
an organ that causes loss of
parenchymal cells.
Cytokinesis: division of the
cytoplasm of a cell following the
division of the nucleus.
C ploidy values, Cytokinesis: C
indicates chromatin amount or DNA
content, as a multiple of the haploid
genome.
Dedifferentiation: reversion of
specialized postmitotic cells to a
more primitive phenotype or
differentiation status. Dedifferentiated
cells are unable to perform the
specialized function but that can
complete mitotic cell divisions.
Endocycle: alternative cell cycle
passing once – or even multiple
times – through G and S phases
while skipping M phase in its entirety
and resulting in the formation of
polyploid mononuclear cells.
Endomitosis: alternative cell cycle
passing once – or even multiple
times – through G1, S, and G2/M
phases without nuclear division
(chromatids are separated but in a
single nuclear envelope) or with
nuclear division but no cytokinesis,
resulting in the formation of mono or
polynuclear cells, respectively.
Endoreplication: incomplete cell
cycle that replicates DNA during the
S phase without the completion of
mitosis or cytokinesis.
Hypertrophy: increase in size (the
term can be used for a cell or an
organ). Hypertrophy usually results
from an increased workload due to
some physical defect, such as when
an organ is partially damaged or
nonfunctional.
Mitosis: act of cell division that
results in two daughter cells with a
DNA content of 2n.
n ploidy values: n indicates the
number of sets of chromosomes, as
a multiple of the haploid genome: 1n
is the chromosome content of a
germinal cell, 2n is the chromosomal
content of a somatic diploid cell.
Polyploid cell: cell that has more
than a diploid copy of its genome.
Polyploid cells arises from cell cycle
dependent mechanisms (endocycle
and endomitosis), thereby generatingcontent rather than cell number. This response is highly conserved across evolution [29–31].
Finally, polyploidization permits genomic buffering against DNA-damaging agents or mutations
and provides a more efficient protective barrier owing to a lower density of cell–cell junctions that
helps to deal with exposure to toxic or infectious agents [8].
Cell Cycle Regulation towards Either Polyploidization or Proliferation
The diversity of cell cycle programming in response to acute tissue injury is increasingly
appreciated [5]. Although the cell cycle regulators in endoreplication and mitosis are mostly the
same, two essential cell cycle modifications are needed in order to undergo endoreplication
instead of the mitotic cell cycle, that is, downregulating the activity of those cyclin-dependent
kinases normally driving G2/M phase progression (M-CDK) and maintaining the activity of the
CDK responsible for S-phase entry (S-CDK) (Figure 1). First, inhibition of the mitotic machinery
occurs by downregulating M-CDK complex activity, in which CDK1 is bound and activated by
cyclin B or cyclin A, and by sustaining the S-CDK complex activity, in which CDK2 is bound
and activated by cyclin E (Figure 1) [5,25]. E2F transcription factors are divided into activator
(E2F1–3) and repressor (E2F4–6) subclasses. In the latter subclass, two new repressors were
recently added (E2F7–8) and were shown to be critical regulators of the transition from G to S
phase by the transcriptional inhibition of cyclin E, impairing the formation of the CDK2–cyclin E
complex (Figure 1) [32]. By the balancing of E2F proteins, mammalian cells can regulate the
oscillation of CDK2–cyclin E activity, from low-to-high in the G to S phase, enabling cells to
regulate mitosis as well as transition from mitosis to endocycle in cells that are unable to
proliferate (Figure 1) [32,33]. Indeed, the activity of atypical E2F8 repressor drives hepatocyte
binucleation and polyploidization, whereas its deficiency leads to an increase in the expression
level of E2F target genes promoting cytokinesis (Figure 1) [32]. The second modification
requires inhibition of the mitotic machinery by targeting mitotic cyclins for proteolytic degra-
dation via the anaphase-promoting complex/cyclosome (APC/C) E3 ligase (Figure 1). The
Fizzy-related receptor (Fzr), the Drosophila homolog of mammalian FZR1/CDH1, a binding
partner of the APC/C, is a regulator of cell cycle programming in adult differentiated cells, and
dictates the decision between mitosis and endocycle by facilitating degradation of cyclin B or
cyclin A, preventing the formation of the M-CDK complex (Figure 1) [29]. Another regulator of
polyploidization is the Hippo/Yap signaling pathway (Figure 1) [34,35]. Yap promotes polyploid
cell growth by regulating Skp2, an E3 ligase that targets p27 for proteolytic degradation [35].
Indeed, the accumulation of p27 causes hepatocytes to move towards endoreplication and to
boost ploidy [35].
Although polyploidization and proliferation require distinct cell cycle machineries, cells can
occasionally be forced to reprogram their cell cycle in response to stress. However, switching
from polyploidization to mitosis is not feasible for differentiated parenchymal cells with an
endoreplication machinery without entering an aberrant mitosis and mitotic catastrophe. The
consequences are further parenchymal loss and organ function impairment [9,10,17].
Polyploidization and Progenitor Proliferation in the Liver
Postnatal hepatocyte polyploidization increases with aging. In human adults, polyploidization starts
slowlyatanearlyagebut intensifiesafter50yearswhen20–30%ofhepatocytesarepolyploid [36,37]
compared with >70% of polyploid hepatocytes in adult rodents [37]. The predominant mechanism
leading to polyploidy in rat hepatocytes is endoreplication generating a range of hepatocyte ploidy
from diploid cells (2n, 2C) to polyploid ones (monoorbinucleated cells) with a tetraploid DNA content
(4n, 4C), with an octaploid DNA content (8n, 8C), or with an hexadecaploid DNA content (16n, 16C)
(Figure 2;C ploidy values, n ploidy values) [5,37]. Hepatocytes are gradually replenished during
homeostasis and robustly after liver injury [38]. In adults, new hepatocytes originate from an existingTrends in Molecular Medicine, Month Year, Vol. xx, No. yy 3
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both mono- or multinucleated cells,
and by cell cycle independent
mechanisms (cell fusion).
Polyploidization: mechanism to
increase DNA content with or without
increasing nuclear number.
Progenitor: a cell that can self-
renew and differentiate into one or
more specific cell type(s) to replace
cell loss, during homeostasis and/or
after injury.
Proliferation: mechanism to
increase cell number via cell division
with mitosis.
Regeneration: process leading to
complete restoration of tissue
integrity after injury by replacement of
lost cells with new cells, re-
establishing the organ normal state
and function.
Repair: process leading to complete
or partial restoration of tissue
architecture integrity and function
after injury that can occur by
regeneration and/or by scarring (i.e.,
laying down of connective tissue to
heal the gap).hepatocyte pool [39–41]. Whereas some studies have suggested that, regardless of ploidy, the
capacity of hepatocytes to divide would be randomly distributed [41], recentevidence demonstrates
the existence of a distinct progenitor population [21,38]. In particular, a population of diploid Wnt-
responsive progenitor cells, adjacent to the central vein in the liver lobule, contributes to hepatocyte
maintenance by self-renewing and differentiating into mature hepatocytes, that gradually lose the
capacity to divide and undergo polyploidization [14]. In addition, by using a lineage tracing mouse
model, a subset of hepatocytes that expresses high levels of telomerase displayinghigh self-renewal
capacity, has been identified [38]. These cells, distributed throughout the liver lobule, repopulate the
liver during homeostasis, thus behaving as progenitors [38].
Acute Liver Injury
Some clues to establishing the role of polyploidization and proliferation of hepatocytes following
acute liver injury, may be deduced from data originating in hepatectomy experiments in mice
[28]. After hepatectomy, organ function recovery and restoration of the original liver mass
depend on a sophisticated balance between polyploidization (endoreplication-mediated hyper-
trophy) and proliferation of hepatocytes, respectively [28]. Indeed, functional recovery in a
mouse model with 70% partial hepatectomy was achieved by an increase of ploidy of
hepatocytes (Figure 2) [28]. However, this response is not the only one, but rather precedes
the wave of proliferation of diploid hepatocytes (hepatocyte progenitors) that provide the true
restoration of liver mass (Figure 2) [28]. Accordingly, blocking mitosis through the conditional
knockout of CDK1 in a mouse liver did not impair recovery of liver function mediated by
polyploidization upon 70% partial hepatectomy, indicating that polyploid cells are crucial
players in supporting and maintaining almost normal liver function [42]. In contrast, by using a
model of polyploidy knockout (E2F7/E2F8 knockout mice) with 70% partial hepatectomy,
Wilkinson et al. demonstrated that a true mitotic cell division occurs and is driven mostly by a
small population of diploid hepatocyte progenitors, representing about 10% of all hepatocytes
[20]. Moreover, proliferation of hepatocyte progenitors occurs sooner and faster than poly-
ploidization in differentiated hepatocytes and is responsible for the true structural recovery of
the organ [20]. Consistently, hepatocyte progenitors also clonally expand after acute toxic injury
by CCl4 injection in order to maintain liver mass [38]. A comparative genome-scale analysis
demonstrated that gene expression varies in diploid, tetraploid, or octaploid hepatocytes
[43,44]. Compared with diploid hepatocytes, polyploid hepatocytes revealed a tendency to
switch from fatty acids to glucose oxidation, in order to increase anaerobic energy production
and to obtain ATP in long-term energy starvation periods such as in acute organ injury [43,44].
Overall, polyploidy increases tissue-specific transcription and function, and promotes adapta-
tion to energy depletion and to stressful environments [43,44]. This scenario confirms that only
a small population of hepatocyte progenitors invests energy in cell division, whereas the
majority of hepatocytes become polyploid and invests energy in sustaining liver function. Thus,
the functional recovery and restoration of liver mass after acute injury is achieved by selection of
several ploidy classes endowed with specialized functions inside the liver. In summary, whereas
polyploid differentiated hepatocytes drive the functional recovery, increasing the output of
metabolic function, hepatocyte progenitors drive the restoration of liver mass by generating
new hepatocytes by a process of proliferation and differentiation.
Polyploidization and Progenitor Proliferation in the Heart
The adult mammalian heart has long been considered an organ lacking any regenerative
capacity due to the inability of terminally differentiated cardiomyocytes to divide [19,45].
Indeed, the muscular pump must continuously operate and hence it invests all its energy into
contractile activity [43,45]. Mitosis and cytokinesis would require disintegration of sarco-
meres, implying a potentially fatal temporary loss of contractile function [43]. Alternatively,4 Trends in Molecular Medicine, Month Year, Vol. xx, No. yy
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Figure 1. Two Ways of Compensating Parenchymal Cell Loss: Polyploidization via Endocycle and Endomitosis of Differentiated Cells and
Regeneration via Proliferation of Local Progenitors. Note that endoreplication via endomitosis or endocycle results in mono/multinuclear polyploid cells. Mitosis
requires activation of the transcription factors E2F1–3. E2F1–3 control G1/S phase through transcriptional activation of the complex S-CDK composed of cyclin E
(CycE), which binds to and activates cyclin dependent kinase (Cdk)2. E2F1–3 also activate the expression of E2F7–8, which in turn repress expression of E2F1–3, thus
forming a negative feedback loop. E2F1–3 is also required for the expression of cyclin A and B (CycA and CycB) which activate Cdk1, forming the mitotic cyclin
dependent complex M-CDK responsible for G2M-phase progression. The activity of M-CDK is modulated by the complex anaphase-promoting complex/cyclosome
(APC/C) E3 ligase and Cdh1. The switch to polyploidization (endocycle or endomitosis) requires: a high expression of E2F7–8, which inhibits M-CDK and cytokinesis,
the strong activity of APC/C Cdh1, and the inhibition of the Hippo signaling pathway.
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Figure 2. Hepatocyte Polyploidization and Progenitor Proliferation Repair of Acute Liver Injury. The response to liver injury after a 70% partial hepatectomy
is achieved by polyploidization which facilitates the preservation of organ function, but precedes the wave of hepatocyte progenitor proliferation that restores liver mass.
Postinjury livers are, thus, characterized by division of diploid cells and by subsequent division of polyploid cells via endoreplication, generating tetraploid, octaploid, and
hexadecaploid cells and providing heterogenous cellular patterns of DNA content and numbers of nuclei. Abbreviations: CV, central vein.
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TRMOME 1423 1–16polyploidization allows adding more sarcomeres while maintaining contractile performance
upon injury-related cell loss [43,45].
However, recent studies have demonstrated a low but constant rate of cardiomyocyte turnover
in the adult mammalian heart [46–49]. Newly generated cardiomyocytes originate from a
subpopulation of pre-existing cardiomyocytes that retain their proliferative capacity throughout
adulthood [19,22,46–50]. Several studies have suggested that these may represent a popula-
tion of cardiomyocyte progenitors [19,22,51,52]. Cardiomyocyte progenitors were identified in
the adult mouse and human heart by using a variety of approaches: (i) the expression of surface
markers such as c-Kit [51,53] or Sca1 (even if no human ortholog exists) [54]; (ii) the demon-
stration of physiological properties such as the ability to efflux Hoechst dye [55] or to form
cardiospheres in culture [56], and (iii) by lineage tracing at a single-cell level [22,52].
Acute Heart Injury
When acute ischemic injury occurs in the heart, cardiomyocyte progenitors can proliferate but
this ability declines with age in mammalian hearts (Figure 3) [19,22,52–54,57,58]. Indeed,
neonatal murine hearts can regenerate efficiently after injury [59], mirroring what happens in
lower vertebrates (Figure 3) [60–62]. Of note, the main marker of nonregenerative versus
regenerative heart is the DNA content of cardiomyocytes [62]. Indeed, heart aging is charac-
terized by a lower regenerative capacity and increased polyploidy, even resulting in cardiac
hypertrophy in the long run [62]. Specifically, nonregenerative hearts such as mammalian adult
hearts, contain a majority of polyploid cardiomyocytes whereas highly regenerative hearts, such
as mammalian neonate and zebrafish hearts, contain a majority of diploid cardiomyocytes,
regarded as progenitors (Figure 3) [62]. By using a transgenic strategy in zebrafish to resemble
the behavior of mammalian adult hearts, the increment of myocardial polyploidization above
50% is sufficient to dampen regeneration and promote scarring (Figure 3). This suggests that
polyploid cardiomyocytes create a barrier to heart regeneration, which is detrimental in the long
term and only rare cardiomyocyte progenitors proliferate and provide tissue regeneration [62].
Similar to hepatocyte polyploidy, cardiomyocyte polyploidy is associated with a switch of
tissue-specific functions to an energy-saving mode [43]. This switch is demonstrated by the
substitution of highly effective and energy-intensive proteins with economic energy-saving
proteins at the expense of velocity of contraction [43]. For example, in polyploid cells, the
a-myosin heavy chain (fast and adult) is substituted by the b-myosin heavy chain (slow and
embryonic) [43]. b-Myosin heavy chains require 3–5-fold less ATP for contraction than a-myo-
sin heavy chains require [43]. Therefore, the overexpression of slow (b) myosin heavy chains is a
commonly used marker of cardiac energy starvation in experimental models of heart disease
and human hypertensive heart disease, dilated cardiomyopathy, myocardial infarction, and
hypoxia [43]. The evidence that all these diseases are accompanied by cardiomyocyte poly-
ploidy suggests a tight link between polyploidization and changes in myosin heavy chain
isoforms [45].
Overall, in the early phase of injury, polyploidization of cardiomyocytes and regeneration driven
by cardiomyocyte progenitors are critical to maintain heart function and to restore tissue
integrity, respectively. However, polyploidization can be detrimental in the long term, as it is
associated with scarring and chronic heart failure.
Polyploidization and Progenitor Proliferation in the Kidney
Every kidney consists of several hundreds of thousands of independent functional units, that is,
nephrons. Kidney injury does not affect all nephrons equally, hence uninjured nephrons have to
compensate for the function of lost or severely injured nephrons. Each nephron is composed ofTrends in Molecular Medicine, Month Year, Vol. xx, No. yy 7
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Figure 3. Cardiomyocyte Polyploidization and Progenitor Proliferation Repair Acute Heart Injury. The most prevalent type of cellular response can be
different in different species and at different phases of life. In neonates, the high number of cardiomyocyte progenitors (light blue cells) guarantees regeneration of injured
areas by proliferation. In young mammals, the number of cardiomyocyte progenitors decreases and organ repair is guaranteed by both mechanisms: proliferation of a
subset of cardiomyocytes endowed with progenitor capacity and polyploidization of cardiomyocytes. In adults, the lack of sufficient numbers of progenitors in the heart
impedes sufficient regeneration. Therefore, mesenchymal healing remains the only viable option beyond cardiomyocyte hypertrophy which leads to focal or diffuse scar
formation, depending on the nature of the injury. The polyploidization strategy is sufficient to dampen regeneration and promote scarring, suggesting that polyploid
cardiomyocytes create a barrier to heart regeneration.two morphologically and functionally distinct compartments, that is, the glomeruli and tubuli,
built by unique, highly specialized epithelial cells. The glomeruli contain two types of epithelial
cells, parietal epithelial cells located along the Bowman’s capsule and podocytes located along
the glomerular filtration barrier (Figure 4). Podocytes are highly differentiated epithelial cells that
form unique cytoplasmic extensions, foot processes, interdigitating with those of neighboring
podocytes (Figure 4). Maintaining these sophisticated structural elements requires an intricate
actin cytoskeleton [63,64]. Therefore, podocytes cannot complete cytokinesis [17,65]. How-
ever, parietal epithelial cells along the Bowman’s capsule harbor resident podocyte progenitors
that can provide new podocytes during kidney growth [66–69], but not in aging mice under
physiological conditions [66]. Tubular epithelial cells were considered a homogeneous popu-
lation of diploid cells showing the same potential to re-enter the cell cycle [70]. However, several
studies have suggested the existence of a specific subset of more immature tubular cells
displaying higher self-renewal potential, referred to as tubular progenitors (Figure 4) [23,71,72].
Proliferation markers used as indirect indicators of cell division suggest a constant tubular
turnover from resident tubular epithelial cells (Box 1) [70]. However, a low percentage of
polyploid tubular cells have recently been demonstrated in healthy adult mice [23]. Since
glomeruli and tubuli are differently affected by specific disorders we discuss them separately.8 Trends in Molecular Medicine, Month Year, Vol. xx, No. yy
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Box 1. Distinguishing Polyploidization from Proliferation
A major challenge in the tissue growth and regeneration field has been to faithfully distinguish between polyploidization
and proliferative cell cycle events. Sophisticated strategies are now being used to conclusively detect a complete mitotic
cell cycle resulting in cytokinesis and generation of two diploid daughter cells versus endoreplication generating
polyploid cells.
Cell Cycle Markers
S-phase markers [proliferating cell nuclear antigen (PCNA), 3H-thymidine, 5-ethynyl-20-deoxyuridine (EdU), or 5-bromo-
20-deoxyuridine (BrdU)] do not distinguish endoreplication from a mitotic cell division, since in both cases cells will enter
S phase and express cell cycle markers. Likewise, the G2/M phase marker, phospho-histone H3 (pH3), does not
differentiate between endomitosis and mitotic cell division, as chromosomes condense during metaphase and are
readily labeled with pH3 in both cell cycles [106]. The Ki67 marker labels all phases of the cell cycle and only
distinguishes cycling cells from postmitotic cells [107]. No cell cycle marker exists that can distinguish cell division
that results in a diploid versus a polyploidy cell.
DNA Content Analysis
This strategy allows the measurement of cell nuclear DNA content (ploidy) in order to distinguish between diploid (4C, C
ploidy value) and polyploid (4C) cells with a rigorous method. DNA content analysis can be performed with several
methods: (i) by imaging fixed cells in which DNA is stained with 40,6-diamidino-2-phenylindole (DAPI) and a quantitative
analysis of the fluorescence intensity is performed [30]; (ii) by cell cycle analysis with fluorescence-activated-cell sorting
[108]; and (iii) by single-cell DNA sequencing [109].
Cell Cycle Live Imaging
Cell cycle live imaging in combination with fluorescent reporters allows us to detect all phases of the cell cycle to follow
cell division in transgenic mice in vivo. This strategy based on fluorescent ubiquitination-based cell cycle indicator
(FUCCI) technology, allows us to distinguish nuclei of cells in G1 phase, expressing the fluorescent protein mCherry,
from nuclei of cells in S/G2/M phase, expressing the fluorescent protein mVenus [110]. As a result of this technology, cell
cycle phase analysis performed contemporarily with the measurement of DNA content, can distinguish between diploid
(4C) and polyploid (4C) cells in cell cultures or in organs [110]. This emerging technique has led to a significant
recognition of the presence of polyploidy in several organs, and puts into question the classic concept about tissue
growth during development and repair after injury [23,50,86].Acute Glomerular Injury
After acute glomerular injury, podocytes undergo hypertrophy by DNA synthesis and G2/M
arrest and eventually polyploidization in an attempt to cover the underlying glomerular base-
ment membrane in exposed areas from where neighboring cells have detached or died
(Figure 4) [63,64,73–75]. However, if the injury exceeds a certain threshold, podocyte hyper-
trophy becomes an unfit strategy over time and, by forcing mitosis, podocytes usually generate
aneuploid cells that detach and die by mitotic catastrophe (Figure 4) [17,65]. In addition, lost
podocytes can be replaced by podocyte progenitors that contribute to the restoration of the
leaky filtration barrier and recover kidney function, improving outcome (Figure 4) [69,76–79].
Podocyte progenitors are not equally distributed across nephrons. While superficial cortical
nephrons are smaller, have fewer podocytes, and are well endowed with podocyte progenitors,
juxtamedullary nephrons, in contrast are larger, have more podocytes but fewer progenitors,
hence more frequently succumb to scarring upon glomerular injury [79].Figure 4. Renal Epithelial Cell Polyploidization and Progenitor Proliferation Repair of Acute Kidney Injury
For a Figure360 author presentation of Figure 4, see the figure legend at https://10.1016/j.molmed.2019.02.006
The kidney responds to acute injury with two separate strategies: local progenitor cells produce new podocytes on the glomerular tuft or new tubular cells depending on
the site of injury and epithelial cell loss. In the glomeruli, differentiated podocytes cannot undergo cytokinesis and increase their working capacity by entering the cell
cycle to increase their DNA content and become polyploid. At the same time, podocyte progenitors localized among parietal epithelial cells of the Bowman’s capsule
differentiate and replace lost podocytes. Tubular epithelial cells that are already fully engaged in essential organ functions increase their working capacity without any
interruption by entering the cell cycle to increase their DNA content; a form of alternative cell cycle named endoreplication. This process allows differentiated cells in
uninjured S2 segments a compensatory hypertrophy to take over the filtration load of nonfunctioning injured or lost nephrons, while tubular progenitors scattered along
the nephron proliferate, completing cell division and drive regeneration in necrotic S3 segments of the proximal tubule of affected nephrons.
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Clinician’s Corner
Acute Heart Injury
Acute, focal cardiac injuries, for exam-
ple, due to regional ischemia, can lead
to infarction areas. Heart injury is indi-
cated by an increase in serum levels of
troponins or creatinine kinase [102].
Acute heart failure is indicated by an
acute drop in ejection fraction [102].
Current treatments include fluid con-
trol, vasopressors, inotropic medica-
tions, antiarrhythmic drugs, or
ultimately ventricular assist devices
[102]. Shifting from polyploidization
to proliferation can improve heart func-
tion after acute myocardial infarction in
animal models suggesting this may
represent a potential target for future
treatments [100,101].
Hypertrophy/polyploidization of cardi-
omyocytes in the unaffected regions of
the left ventricle reduces short-term
mortality by sustaining cardiac output
[103]. In contrast to other organisms,
adult mammalian hearts lack a major
proliferative response involving cardio-
myocyte progenitors and their contri-
bution to sustained cardiac function is
still debated. After the acute phase,
current treatment protocols aim to
reduce left ventricular wall stress as
a stimulus for persistent cardiomyo-
cyte hypertrophy and cardiac remod-
eling, which otherwise drives morbidity
and mortality from subsequent heart
failure.
Acute Liver Injury
Acute liver injury most commonly
involves diffuse hepatocyte necrosis
secondary to toxins or bacterial and
viral infections, congestion (right heart
failure or liver vein thrombosis), as well
as autoimmunity. Liver injury is indi-
cated by an increase in serum levels
of liver enzymes. Liver failure is indi-
cated by a reduction of coagulation
factors, cholinesterase or albumin.
Current treatment targets the specific
cause of liver failure if possible and it
includes supportive management of
secondary complications. Ultimately,
liver assist devices and liver transplan-
tation are options where available
[104]. Polyploidization and hepatocyte
(progenitor) proliferation both occur in
hepatocytes in injured adult mamma-
lian liver and seem to synergisticallyAcute Tubular Necrosis
In the kidney, the term polyploidy has long been associated solely with podocytes. Acute
tubular necrosis (ATN) has long been considered largely reversible based on the capacity of
surviving tubular cells to dedifferentiate and replace lost cells via cell division [70,80]. Staining for
classical proliferation markers has suggested that fully differentiated tubular cells act as a
reserve that promptly re-enters the cell cycle upon injury (Box 1) [70]. However, recent studies
have demonstrated that tubular regeneration may involve tubular progenitors [23,71,72]. In
particular, a combination of fluorescent ubiquitination-based cell cycle indicator (FUCCI)
transgenic labeling of the cell cycle phase with DNA content analysis, has demonstrated that
injured tubules respond to ATN through two main mechanisms (Box 1) (Figure 4): (i) endor-
eplication-mediated hypertrophy of remnant tubular epithelial cells, aimed at sustaining renal
function despite significant epithelial cell necrosis; and (ii) survival and proliferation of tubular
progenitors, aimed at replacing lost tubular cells. Tubular progenitors represent a subset of
scattered immature epithelial cells that retain the capacity for clonal cell division and can
regenerate necrotic tubule segments [23]. The recognition of polyploid tubular cells in the
kidney was particularly challenging because polyploid cells mostly maintain a single nucleus
(Box 1) [23]. Tubular cell-endoreplication after ATN compensates for the decline of renal
function associated with tubular cell necrosis and the irreversible demise of some nephrons.
Although it may not restore tubular integrity in injured nephrons, this mechanism is certainly of
importance when handling the sudden increase in filtration load in uninjured nephrons. Never-
theless, lineage tracing experiments in mice have demonstrated that tubule progenitors
undergo clonal expansion in order to replace lost tubular cells in the necrotic S3 segments
of the proximal tubule in affected nephrons, contributing to the structure recovery (Figure 4)
[23]. In contrast, tubular cell endoreplication is frequently observed in other nephron segments,
in particular the proximal convoluted tubule (S2 segment), that is not directly injured during ATN
(Figure 4). Likewise, this response probably occurs in uninjured nephrons even if dissecting
affected nephrons from unaffected nephrons is technically challenging due to their complex 3D
structure [23].
In summary, podocytes and tubular cells share similar mechanisms of response to injury.
Indeed, polyploidization-induced hypertrophy and progenitor proliferation contribute to the
recovery of glomerular as well as tubular injuries in analogy to what was previously described
with regard to the heart and liver.
Polyploidization and Proliferation in Other Solid Organs
In other organs, evidence of a combined contribution of proliferation and polyploidization in
repairing acute injury is still limited; mostly because new techniques that could allow us to
distinguish mononuclear polyploid cells from diploid ones have yet to be applied.
In the lung, response to acute tissue injury is mediated by different types of progenitor cells, that
proliferate and migrate to more peripheral regions. Although polyploidization has not yet been
described in the lung, it has been reported in the bronchi [81].
In the pancreas, endocrine and exocrine cells undergo programmed polyploidization during
weaning resulting in cells with different ploidy status [82]. However, in the exocrine pancreas,
polyploidization mildly contributes to function recovery after injury [82], while new acinar cells
are mostly generated by proliferation of survived acinar cells [83], or through proliferation of the
metaplastic duct-like cells [83]. In the endocrine pancreas, the response to acute injury involves
modest proliferation of existing cells and/or putative progenitors as well as hypertrophy [84].Trends in Molecular Medicine, Month Year, Vol. xx, No. yy 11
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contribute to the recovery of liver func-
tion and mass. Polyploidization is obvi-
ous in multinucleated hepatocytes
(endomitosis) and it is also present in
humans. Whether interfering with one
of the two or both mechanisms could
improve outcomes in patients with
acute liver injury is still unknown.
Acute Kidney Injury
Acute kidney injury often involves dif-
fuse necrosis of S3 segments of proxi-
mal tubules due to toxins, ischemia,
sepsis (often all in combination), alloim-
munity, or autoimmunity. Urinary kid-
ney injury markers include insulin-like
growth factor-binding protein 7
(IGFBP7) and tissue inhibitor of metal-
loproteinase 2 (TIMP2). Renal failure is
indicated by a decrease in urinary out-
put and/or an increase in serum creat-
inine levels [105]. Current treatments
include abrogating the causative stim-
ulus, control of fluids, electrolytes and
metabolic acidosis, eventually employ-
ing peritoneal or hemodialysis [105].
Proliferation of tubular progenitors
and polyploidization of differentiated
tubular epithelial cells synergize to rap-
idly recover kidney function. In mice,
pharmacological stimulation of pro-
genitor proliferation can enforce func-
tion recovery by preventing irreversible
loss of injured nephrons. Whether this
approach is feasible and safe also in
humans is currently unknown.In the bladder and excretory system, polyploidization and progenitor proliferation were recently
described in the urinary epithelium (urothelium) during homeostasis and after acute injury. A
population of diploid progenitors replaces binucleated superficial cells as they die off after injury,
thereby maintaining the urothelium barrier [85].
Polyploidization and progenitor proliferation were recently described also in the epicardium.
Mechanical tension drives both endocycle and endomitosis for generation of polyploid epicar-
dial cells. After heart repair, the polyploid cells are cleared by apoptosis and replaced by
epicardial progenitors [86].
Polyploidization and Proliferation: Trade-offs and Therapeutic Windows
The survival benefits of polyploidization and proliferation are associated with distinct trade-offs
[8]. For example, excessive polyploidization due to repetitive injury or aging can lead to fibrosis.
Indeed, cell cycle arrest upon polyploidization and cellular hyperfunction represents a hyper-
secretory state that is also associated with a persistent secretion of profibrotic mediators driving
fibrogenesis, that is, cell senescence [87]. The association of tissue polyploidization, fibrosis,
and senescence, has been demonstrated for the liver [88,89], heart [89,90], and is likely to
account also for kidney fibrosis [91]. In all of these organs, polyploidization may also lead to
fibrosis and organ dysfunction through another mechanism. Indeed, podocytes and cardio-
myocytes cannot efficiently complete mitosis and when polyploidization does not involve
growth arrest, cells can be forced to pass the M phase and die through mitotic catastrophe,
implying further cell loss [9,17]. Examples of podocyte polyploidization followed by mitotic
catastrophe and further podocyte loss have been reported in most glomerular disorders.
Likewise, when cardiomyocytes are forced to re-enter the cell cycle, they die through mitotic
catastrophe, resulting in cardiomyocyte loss and impaired cardiac function as in dilated
cardiomyopathy and heart failure [9].
Vice versa, progenitor cell proliferation prevents fibrosis and cell senescence. For example, in
the liver, organ aging is characterized by a lower regenerative capacity due to the decline of
progenitor proliferation and/or progenitor loss and increase of polyploid hepatocytes [37]. In
addition, fibrosis is rare in high turnover organs such as the skin or the intestinal tract. These
organs are more often affected by cancer. Solid organs utilizing progenitor-driven repair can
develop cancer, for example, the liver and possibly the renal tubules. Indeed, in mutagen- and
high-fat-induced mouse models, tumorigenesis was accelerated by proliferation of diploid
hepatocytes [92], and accordingly, human data show that, for example, hepatocarcinomas are
predominantly diploid [93–95]. Consistently, in mouse models of a stable polyploidy knockout,
hepatocyte progenitors proliferate faster than in wild-type mice and become highly tumorigenic
when challenged with tumor-promoting stimuli, suggesting that tumors are driven by rapid
progenitor proliferation [20]. Preliminary evidence indicates that renal tumors, such as angio-
myolipoma [96], papillary carcinoma, and clear cell carcinoma, may derive from tubular
progenitors [97,98]. By contrast, the glomeruli and the heart, in which polyploidization pre-
dominates, are largely devoid of cancerogenesis, demonstrating a tumor-suppressive function
by polyploidy [92,93]. However, it is still debated if the increased ploidy or the aneuploidy cause
genome-destabilizing effects and provide another avenue for tumorigenesis [99]. Indeed,
hepatocytes with a specific aneuploid karyotype can be differentially resistant to toxic injury
[99]. A similar mechanism might also be valid for the adaptation of tumor cells, in which loss or
gain of chromosomes provides a growth advantage [99].
The same mechanisms and their trade-offs also represent potential windows of opportunities to
develop promising therapeutic strategies for acute organ failure. In fact, overexpression of12 Trends in Molecular Medicine, Month Year, Vol. xx, No. yy
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Outstanding Questions
Both mechanisms, polyploidization
and proliferation, have their pros and
cons and it may be difficult to avoid the
consequences of their dysregulation.
Can/could pharmacological modula-
tion of the balance between polyploid-
ization and proliferation improve acute
organ failure outcomes without
increasing the risk of the associated
trade-offs such as cancer or fibrosis?
The possibility to modulate the intrinsic
regenerative potential by acting on the
balance between polyploidization and
proliferation could be a new therapeu-
tic window but stimulating one side
may increase the risk of the related
trade-offs. Can/could we identify win-
dows-of-opportunity in terms of dos-
ing or treatment intervals to minimize
the risk of adverse effects from such
therapeutic interventions?
Polyploidization is associated with
fibrosis. This suggests that a quantifi-
cation of polyploid cells could predict
the development of fibrosis. Could
diagnostic evaluation of polyploidiza-
tion of parenchymal cells in the heart,
liver, and kidney, be considered as a
new predictor of subsequent organ
fibrosis? Could polyploidization be a
molecular target to prevent organ
fibrosis in the long run?
Solid organs involving progenitor-
driven repairs can develop cancer,
suggesting that tumors are driven by
rapid proliferation of progenitors, for
example, in the liver and renal tubules.
Which types of cancer may evolve
from local tissue progenitors and their
regenerative response after a previous
episode of organ failure?
In mouse models of a stable polyploidy
knockout, it has been demonstrated
that polyploidy is a protective barrier
against excessive proliferation. Indeed,
if there is a lack of polyploid response,
progenitors are forced to proliferate,
becoming tumorigenic when chal-
lenged with tumor-promoting stimuli.
What determines whether polyploidy
is a barrier or driver for tissue repair?
How does the extent of damage deter-
mine the balance between endorepli-
cation or proliferation? Does the extent
of polyploidization influence the prolif-
eration rate of progenitors?CDK1, CDK4, cyclin B1, and cyclin D1 significantly improved heart function after acute
myocardial infarction by inducing efficient division of cardiomyocytes [100]. Likewise, cardi-
omyocyte proliferation is promoted during pregnancy and after myocardial infarction by factors
produced by T-regulatory cells, thus improving outcomes, suggesting that it could represent a
potential therapeutic target [101].
In the kidney, stimulating proliferation of podocytes or tubular progenitors has been proposed
as a new strategy to regenerate injured nephrons. Stimulating podocyte progenitors from
along the Bowman’s capsule to migrate to the glomerular tuft and to differentiate into new
podocytes is efficiently achieved by the inhibition of GSK3b (BIO) or CXCL12 [69,79].
Strikingly, both treatments attenuate proteinuria and chronic kidney disease (CKD) progres-
sion, highlighting the critical role of podocyte progenitors for either resolution or progression
of glomerular diseases [69,77,78]. Likewise, drugs that target tubular progenitor proliferation,
such as histone deacetylase inhibitors (HDACi), trichostatin, (TSA) and 4-phenylbutyrate (4-
PBA), accelerate the intrinsic capacity of the kidney for tubular regeneration upon ATN [23].
Their effect results from a selective expansion of tubular progenitors, restoring tubular cell
number and reconstituting tubular integrity. Tubular progenitor proliferation results in sus-
tained recovery of renal function, avoiding development of tissue fibrosis and CKD [23]. It
remains to be explored if enhancing kidney regeneration implies a higher risk for subsequent
kidney cancer.
Concluding Remarks and Future Perspectives
Acute solid organ injury can present itself with or without organ failure. In the life-threatening
setting of organ failure, survival depends on the maximal working capacity of the remnant
parenchymal cells, which are also highly differentiated postmitotic cells. These two con-
siderations argue against the previous concept of dedifferentiation and proliferation. New
data can now resolve this conflict. Only a small subpopulation of more immature paren-
chymal cells, referred to as local progenitors, proliferate and differentiate to replace at least
some of the irreversible loss of parenchymal cells during injury. The vast majority of the
differentiated parenchymal cells also enter the cell cycle (explaining the widespread posi-
tivity of cell cycle markers often miscalled proliferation markers) but do not undergo cell
division. The structural consequence of polyploidization is cell hypertrophy. The functional
consequence of polyploidization is increased working capacity. Both mechanisms together
allow context-dependent and dynamic responses to different extents and possibly also to
different types of injury. Experimental studies demonstrate therapeutic potential on short-
term outcomes by targeting both mechanisms, but possible harmful effects warrant caution
and deserve further investigation. Progenitor-related tumorigenesis and polyploidization-
related senescence and tissue fibrosis may significantly impair long-term prognosis in those
who survive the acute phase. These and other important questions for further research are
highlighted in the Outstanding Questions. Another important conclusion, expanding the
view from within each research domain to other research domains that are tackling similar
problems, may reveal unexpected similarities in the available data and provide a conceptual
framework providing guidance in all the fields. Evolutionary pressure has been similar for the
heart, liver, and kidney, as well as for other solid organs. It is more than likely that the cellular
constituent, that is, postmitotic cells and resident progenitors, albeit of different shapes, are
similar, as are the responses to injury.
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